Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Q Jean Zhou

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Journal of Organic Chemistry|July 17, 2004
10-hydroxy-10,9-boroxarophenanthrenes: versatile synthetic intermediates to 3,4-benzocoumarins and triarylsQ Jean Zhou, Karin Worm, Roland E Dolle
Bioorganic & Medicinal Chemistry Letters|May 18, 2007
Biaryl cannabinoid mimetics--synthesis and structure-activity relationshipKarin Worm, Q Jean Zhou, Gabriel J Stabley, et al.
Bioorganic & Medicinal Chemistry Letters|April 24, 2008
Sulfamoyl benzamides as novel CB2 cannabinoid receptor ligandsKarin Worm, Q Jean Zhou, Christopher T Saeui, et al.
Journal of Medicinal Chemistry|August 22, 2009
Spirocyclic delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-3-hydroxy-4-(spiro[chromene-2,4'-piperidine]-4-yl) benzamide (ADL5747)Bertrand Le Bourdonnec, Rolf T Windh, Lara K Leister, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Journal of Organic Chemistry|July 17, 2004
10-hydroxy-10,9-boroxarophenanthrenes: versatile synthetic intermediates to 3,4-benzocoumarins and triarylsQ Jean Zhou, Karin Worm, Roland E Dolle
Bioorganic & Medicinal Chemistry Letters|May 18, 2007
Biaryl cannabinoid mimetics--synthesis and structure-activity relationshipKarin Worm, Q Jean Zhou, Gabriel J Stabley, et al.
Bioorganic & Medicinal Chemistry Letters|April 24, 2008
Sulfamoyl benzamides as novel CB2 cannabinoid receptor ligandsKarin Worm, Q Jean Zhou, Christopher T Saeui, et al.
Journal of Medicinal Chemistry|August 22, 2009
Spirocyclic delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-3-hydroxy-4-(spiro[chromene-2,4'-piperidine]-4-yl) benzamide (ADL5747)Bertrand Le Bourdonnec, Rolf T Windh, Lara K Leister, et al.
Pageof 1